Zurich Cantonal Bank
AMRI

Zurich Cantonal Bank’s Albany Molecular Research Inc AMRI Stock Holding History

Zurich Cantonal Bank’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-593
Closed -$13K – 2539
2017
Q2 		$13K Hold
593
– – ﹤0.01% 2382
2017
Q1 		$8K Hold
593
– – ﹤0.01% 2525
2016
Q4 		$11K Hold
593
– – ﹤0.01% 2439
2016
Q3 		$10K Hold
593
– – ﹤0.01% 2424
2016
Q2 		$8K Hold
593
– – ﹤0.01% 2440
2016
Q1 		$9K Hold
593
– – ﹤0.01% 2403
2015
Q4 		$12K Hold
593
– – ﹤0.01% 2322
2015
Q3 		$10K Buy
+593
New +$12.1K ﹤0.01% 2063

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Zurich Cantonal Bank's AMRI Position: Q3 2017 in Review

Zurich Cantonal Bank sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 593 shares — an estimated $13K sold.

Zurich Cantonal Bank first reported a position in AMRI in Q3 2015 and held it in 8 quarters. The position peaked at $13K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Zurich Cantonal Bank reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Zurich Cantonal Bank sold 593 Albany Molecular Research Inc shares in Q3 2017, an estimated $13K.
  • Zurich Cantonal Bank first reported a position in Albany Molecular Research Inc in Q3 2015 and held it in 8 quarters.
  • Zurich Cantonal Bank's Albany Molecular Research Inc position peaked at $13K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Zurich Cantonal Bank's 13F filing for Q3 2017, filed 8 Nov 2017.